TABLE V.
Characteristics | Univariable associations | Final multivariable model | ||
---|---|---|---|---|
Median (IQR) | P value | Unstandardized β coefficient (95% CI) | P value | |
Sex* | <.001 | |||
Female | 52.9 (46.4–56.4) | −1.6 (−2.6 to −0.6) | .001 | |
Male | 54.5 (49.4–57.1) | Reference | ||
Age (y)* | <.001 | −0.1 (−0.1 to −0.05) | <.001 | |
<35 | 55.4 (50.8–57.7) | |||
35–45 | 54.2 (48.8–56.7) | |||
≥45 | 52.9 (50.8–57.8) | |||
Smoking habit* | .064 | |||
Never smoked | 54.2 (48.5–56.7) | |||
Ex-smoker | 52.7 (46.4–56.5) | |||
Current smoker | 54.3 (48.7–56.9) | |||
Body mass index (kg/m2)* | <.001 | |||
<25 | 54.8 (49.9–57.3) | Reference | ||
≥25 | 52.9 (46.3–56.3) | −1.7 (−2.7 to −0.7) | .001 | |
Education level* | .573 | |||
>12 y | 54.2 (48.4–56.7) | |||
≤12 y | 54.1 (48.1–56.7) | |||
Current job duration* | <.001 | |||
<5 y | 54.9 (50.1–57.5) | |||
≥5 y | 53.6 (46.8–56.4) | |||
Asthma preexisting to current job | ||||
Yes | 49.8 (43.5–55.6) | .978 | ||
No | 51.7 (44.4–54.2) | |||
Asthma control | <.001 | |||
ACT score > 19 | 51.7 (45.8–56.2) | |||
ACT score ≤ 19 | 41.2 (37.0–48.4) | |||
Asthma* | <.001 | |||
Absent | 54.4 (49.9–56.7) | Reference | ||
Non-WRA | 51.8 (46.4–56.2) | −2.3 (−3.7 to −0.9) | .002 | |
WRA† | 46.4 (38.6–51.5) | −6.9 (−8.7 to −5.3) | <.001 | |
Depression, physician-based | .001 | |||
Absent | 54.3 (48.7–56.7) | |||
Present | 51.3 (44.1–55.7) | |||
Nonrespiratory, nondepression comorbidity | <.001 | |||
Absent | 54.7 (49.9–57.2) | Reference | ||
Present | 52.8 (44.6–56.2) | −2.3 (−3.4 to −1.3) | <.001 |
IQR, Interquartile range.
Multivariable analysis was done on 822 subjects and incorporated well-known confounders such as age, sex, smoking habits, body mass index, academic level, and current job duration (marked with asterisks) and other covariates with a P value of <.1 in univariable analyses. Asthma control was not included because the information was available only among asthmatic subjects.
Well-known confounders included in the multivariable analysis.
WRA is defined as current asthma associated with ≥2 WRA symptoms.